David W Meline Insider Trading $AMGN AMGEN INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David W Meline.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David W Meline. David W Meline is EVP & CFO in AMGEN INC ($AMGN) and Former Sr. VP & CFO in 3M CO ($MMM) and SR VP & CHIEF FINANCIAL OFCR in 3M CO ($MMM) and VP CORP CNTRLR & CF ACCTG OFCR in 3M CO ($MMM) and Director in ZF TRW AUTOMOTIVE HOLDINGS CORP ($TRW) and Chief Financial Officer in Moderna, Inc. ($MRNA).
David W Meline in AMGEN INC
Trading Symbol: AMGNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David W Meline: EVP & CFO
Holdings: 49,378 shares
Current Value: $8,237,238
Latest Transaction: Nov 25 2019
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David W Meline in AMGEN INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MMM, AMGN, MRNA, TRW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 25 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Sell | S | 234.36 | 8,737 | 2,047,603 | 49,378 | 58.1 K to 49.4 K (-15.03 %) |
May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 177.31 | 39,382 | 6,982,822 | 39,382 | |
May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,511 | 0 | 57,903 | 53.4 K to 57.9 K (+8.45 %) |
May 07 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 176.50 | 795 | 140,318 | 53,392 | 54.2 K to 53.4 K (-1.47 %) |
May 03 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 179.32 | 746 | 133,775 | 54,187 | 54.9 K to 54.2 K (-1.36 %) |
Mar 25 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 191.89 | 8,040 | 1,542,796 | 54,933 | 63 K to 54.9 K (-12.77 %) |
Mar 08 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 16,086 | 0 | 62,746 | 46.7 K to 62.7 K (+34.47 %) |
Feb 01 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 192.11 | 528 | 101,434 | 46,660 | 47.2 K to 46.7 K (-1.12 %) |
Aug 02 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 196.55 | 7,382 | 1,450,932 | 52,202 | 59.6 K to 52.2 K (-12.39 %) |
May 07 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 169.43 | 773 | 130,969 | 59,382 | 60.2 K to 59.4 K (-1.29 %) |
May 01 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 177.46 | 34,702 | 6,158,217 | 34,702 | |
May 01 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,508 | 0 | 60,155 | 55.6 K to 60.2 K (+8.10 %) |
Mar 27 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 176.08 | 7,549 | 1,329,228 | 55,647 | 63.2 K to 55.6 K (-11.95 %) |
Mar 09 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 15,118 | 0 | 62,913 | 47.8 K to 62.9 K (+31.63 %) |
Jan 30 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 198.00 | 496 | 98,208 | 47,795 | 48.3 K to 47.8 K (-1.03 %) |
Aug 01 2017 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 174.51 | 7,562 | 1,319,645 | 47,920 | 55.5 K to 47.9 K (-13.63 %) |
May 03 2017 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 162.60 | 38,126 | 6,199,288 | 38,126 | |
May 03 2017 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,305 | 0 | 55,227 | 50.9 K to 55.2 K (+8.45 %) |
Jan 31 2017 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 157.16 | 529 | 83,138 | 50,690 | 51.2 K to 50.7 K (-1.03 %) |
Aug 03 2016 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 172.03 | 6,766 | 1,163,955 | 50,741 | 57.5 K to 50.7 K (-11.77 %) |
May 05 2016 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 156.35 | 38,112 | 5,958,811 | 38,112 | |
May 05 2016 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,477 | 0 | 57,186 | 52.7 K to 57.2 K (+8.49 %) |
Aug 04 2015 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 176.59 | 7,196 | 1,270,742 | 51,934 | 59.1 K to 51.9 K (-12.17 %) |
Page: 1